TLRY.TO's Sharpe Ratio of -0.24 indicates that for each unit of volatility, it generates -0.24 units of excess return above the risk-free rate. The ratio is calculated using historical daily returns over the past 12 months (as of Jul 21, 2026).
Sharpe uses total volatility (standard deviation) which includes both upside and downside price movements, making it useful for comparing risk-adjusted returns across different assets. For how to read this number and when it can mislead, see Sharpe Ratio Explained.
TLRY.TO Sharpe Ratio Rank
TLRY.TO ranks above 34.9% of all investments in our database based on Sharpe Ratio over the past 12 months, indicating below-average returns relative to volatility. Securities are ranked from 0 (worst) to 100 (best).
What moves the rank
- Strong returns with low total volatility → Higher rank
- High volatility (both upside and downside) → Lower rank
- Consistent returns → Higher rank than volatile returns of same magnitude
- Sharp drawdowns increase volatility → Lower rank
What you can do with this information
- Returns may not adequately compensate for volatility taken
- Consider smaller allocation given below-average risk-adjusted profile
- Explore higher-ranked investments with better consistency
- Assess whether the volatility profile aligns with your portfolio goals
TLRY.TO Sharpe Ratio Market Positioning
The chart shows TLRY.TO's Sharpe Ratio relative to all stocks on our platform, with color zones indicating percentile rankings. Higher ratios indicate better risk-adjusted returns.
- Red zone (bottom 25%): -0.46 or lower
- Yellow zone (middle 50%): -0.46 to 0.95
- Green zone (top 25%): 0.95 or higher
- Top 1%: 4.24+
- Median: 0.10 — half of all investments score higher
How it compares to other similar stocks
The table compares Tilray Brands, Inc.'s Sharpe Ratio with other stocks in the Drug Manufacturers - Specialty & Generic industry across multiple time periods, showing how TLRY.TO's risk-adjusted performance compares to industry peers.
Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jul 21, 2026.
| Symbol | Name | 1Y Sharpe Ratio | 5Y Sharpe Ratio | 10Y Sharpe Ratio | All Time Sharpe Ratio |
|---|---|---|---|---|---|
| GUD.TO | Knight Therapeutics Inc. | 2.57 | |||
| MDP.TO | Medexus Pharmaceuticals Inc. | 1.77 | |||
| CURA.TO | Curaleaf Holdings Inc | 1.75 | |||
| DHT-U.TO | DRI Healthcare Trust | 1.12 | |||
| CRON.TO | Cronos Group Inc. | 0.94 | |||
| CWEB.TO | Charlotte's Web Holdings, Inc. | 0.88 | |||
| CPH.TO | Cipher Pharmaceuticals Inc. | 0.81 | |||
| XLY.TO | Auxly Cannabis Group Inc. | 0.43 | |||
| TSND.TO | TerrAscend Corp | 0.39 | |||
| LABS.TO | MediPharm Labs Corp. | 0.17 | |||
| TLRY.TO | Tilray Brands, Inc. | -0.24 |
Loading charts...
How does TLRY.TO fit in your portfolio?
Add your other holdings to see your portfolio's Sharpe Ratio and find out.
Analyze Your Portfolio